Luke Düster has more than 16 years of experience as both an advisor and investor in high growth companies.  Since joining CRG in 2009, Mr. Düster has helped finance healthcare companies across a wide range of product technologies and therapeutic areas.  He has led investments in companies such as TriVascular, Tandem Diabetes, Nevro Corp., Astute Medical, Good Start Genetics, Nanostring Technologies and others.  Prior to CRG, Mr. Düster was a Vice President at Harris Williams & Co., where he advised private equity and corporate clients across a broad range of M&A assignments.  Mr. Düster also held investment banking roles at the Wallach Company, a regional investment banking boutique, and at the Nord Companies, a healthcare advisory firm.
Mr. Düster received a bachelor’s degree from the University of Colorado at Boulder in 1997, where he graduated summa cum laude. He received an MBA with honors from the Wharton School at the University of Pennsylvania in 2004.